ESR1 and ovarian serous adenocarcinoma: Low-grade serous ovarian cancer seems to be mediated through activation of the MAPK pathway via RAS/RAF and is associated with high levels of estrogen receptor and progesterone receptor expression (Hunter et al., 2015).